Pfizer's oral Covid-19 antiviral cuts hospitalization, death by 85%

General Developer Forum In The News
1

UPDATE: Pfizer’s oral COVID-19 antiviral cuts hospitalization, death by 85%, sending team barreling to FDA.
Pfizer’s oral COVID-19 antiviral has cut the risk of hospitalization or death by 85% in a late-phase trial, prompting the Big Pharma to stop the study and race to seek emergency use authorization from the FDA.

Read in full here:

This thread was posted by one of our members via one of our news source trackers.

2 Likes
2

Corresponding tweet for this thread:

Share link for this tweet.

1 Like
3

hoping this really works and we get another “weapon” to face this pandemic.

2 Likes